Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Pruritus
ADR ID BADD_A03601
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.12      Pruritus NEC
23.03.12.001      Pruritus
Description A disorder characterized by an intense itching sensation. [CTCAE] An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief. [MeSH]
MedDRA Code 10037087
MeSH ID D011537
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Extremities itchy sensation of | General pruritus | Generalised itching | Generalized pruritus | Itch | Itch burning | Itching | Itching - generalised | Itching all over | Itching both hands | Itchy | Itchy legs | Itchy scalp | Itchy skin | Other specified pruritic conditions | Pruritis | Pruritus | Pruritus and related conditions | Pruritus cutaneous | Pruritus facial | Pruritus generalized | Pruritus NOS | Pruritus of both hands | Unspecified pruritic disorder | Pruritus aggravated | Pruritus breast | Hairy skin itching | Pruritus generalised | Localised itching | Localized itching | Generalized itching | Generalised pruritus | Itchy upper limbs | Periorbital pruritus | Localised pruritus | Localized pruritus | Itchy feet | Chronic pruritus of unknown origin | Pruritus sine materia | Nocturnal pruritus
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02398Zuclopenthixol--
BADD_D02415Ziprasidone--
BADD_D02432Glycopyrronium--
BADD_D02446Prasterone0.029625%
BADD_D02449Milnacipran0.000941%
BADD_D02450Crisaborole0.025943%
BADD_D02452Icatibant-
BADD_D02456Vilazodone0.008561%
BADD_D02465Aclidinium0.001389%
BADD_D02472Sonidegib0.000246%
BADD_D02473Sodium chloride0.011055%
BADD_D02475Methylene blue0.000403%
BADD_D02483Ribociclib0.006738%
BADD_D02490Apalutamide0.015716%
BADD_D02495Duvelisib0.000246%
BADD_D02497Avatrombopag0.001555%
BADD_D02500Alpelisib0.003459%
BADD_D02503Telotristat ethyl-
BADD_D02510Rucaparib0.013398%
BADD_D02514Etelcalcetide0.068395%
BADD_D02515Pexidartinib0.006649%
BADD_D02517Enasidenib0.002474%
BADD_D02519Netarsudil0.000548%
BADD_D02524Ivosidenib0.002474%
BADD_D02527Abrocitinib0.002589%
BADD_D02538Calcifediol0.002415%
BADD_D02539Calcium0.002309%
BADD_D02543Clascoterone0.000419%
BADD_D02549Deucravacitinib0.007499%
BADD_D02550Diroximel fumarate0.011839%
The 51th Page    First    Pre   51 52 53    Next   Last    Total 53 Pages